Showing results (21-30 of 87) with videos related to

Sort By:
Pageof 9
Cellular Microbiology|February 14, 2006
Ringing the alarm bells: signalling and apoptosis in influenza virus infected cellsStephan Ludwig, Stephan Pleschka, Oliver Planz, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 18, 2011
Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivoEmanuel Haasbach, Karoline Droebner, Annette B Vogel, et al.
Frontiers in Immunology|June 11, 2026
Zapnometinib treatment and influenza A virus infection modulate the HLA class I ligandome in human lung adenocarcinoma cellsHazem Hamza, Michael Ghosh, Hans-Georg Rammensee, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 16, 2015
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious diseaseValerie L Herrmann, Carmen Hartmayer, Oliver Planz, et al.
Antiviral Research|June 19, 2007
CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in miceKaroline Droebner, Christina Ehrhardt, Anne Poetter, et al.
Microorganisms|April 3, 2021
Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX® and BacterX® ProJulia Koch-Heier, Helen Hoffmann, Michael Schindler, et al.
Pharmaceutics|September 23, 2022
The MEK1/2 Inhibitor ATR-002 (Zapnometinib) Synergistically Potentiates the Antiviral Effect of Direct-Acting Anti-SARS-CoV-2 DrugsAndré Schreiber, Benjamin Ambrosy, Oliver Planz, et al.
Pageof 9